Paul Rivard is CLO at MyMD Pharmaceuticals, Inc. (MYMD). They have made 4 open-market trades across 1 company since 2021, most recently 2023-08-24.
CIK 0001857479
4 open-market purchases totalling $467K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MYMD | 400,000 | $728K |
Shares reported on the most recent Form 4, priced at the 2023-08-24 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.